These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10230308)

  • 1. [Potential opiate withdrawal syndrome after ritonavir administration in a patient treated with methadone].
    Jiménez-Lerma JM; Iraurgi I
    Rev Clin Esp; 1999 Mar; 199(3):188-9. PubMed ID: 10230308
    [No Abstract]   [Full Text] [Related]  

  • 2. Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir-ritonavir.
    Clarke S; Mulcahy F; Bergin C; Reynolds H; Boyle N; Barry M; Back DJ
    Clin Infect Dis; 2002 Apr; 34(8):1143-5. PubMed ID: 11915005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients.
    McCance-Katz EF; Rainey PM; Friedland G; Jatlow P
    Clin Infect Dis; 2003 Aug; 37(4):476-82. PubMed ID: 12905130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic interactions between darunavir/ritonavir and opioid maintenance therapy using methadone or buprenorphine/naloxone.
    Sekar V; Tomaka F; Lefebvre E; De Pauw M; Vangeneugden T; van den Brink W; Hoetelmans R
    J Clin Pharmacol; 2011 Feb; 51(2):271-8. PubMed ID: 20421512
    [No Abstract]   [Full Text] [Related]  

  • 5. Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome.
    Janiri L; Martinotti G; Tonioni F; Ghelardini C; Nicolai R; Galeotti N; Mosconi L; Calvani M; Bartolini A; Iannoni E
    Clin Neuropharmacol; 2009; 32(1):35-40. PubMed ID: 18978503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecstasy and ritonavir.
    Treat Rev; 1997 Apr; (No 24):7. PubMed ID: 11364288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of saquinavir/ritonavir (1000/100 mg bid) on the pharmacokinetics of methadone in opiate-dependent HIV-negative patients on stable methadone maintenance therapy.
    Jamois C; Smith P; Morrison R; Riek M; Patel A; Schmitt C; Morcos PN; Zhang X
    Addict Biol; 2009 Jul; 14(3):321-7. PubMed ID: 19523046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ritonavir (Norvir) and methadone.
    Treat Rev; 1998; (No 28):15. PubMed ID: 11365421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical use of methadone.
    Layson-Wolf C; Goode JV; Small RE
    J Pain Palliat Care Pharmacother; 2002; 16(1):29-59. PubMed ID: 14650449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Opioid treatment of pain in angina pectoris].
    Hermann CK; Eriksen J
    Ugeskr Laeger; 2002 Apr; 164(17):2297-8. PubMed ID: 11989181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone overdose and withdrawal in a tetraplegic patient: a case report.
    Connelly P; Wu H
    PM R; 2014 Aug; 6(8):759-60. PubMed ID: 24594304
    [No Abstract]   [Full Text] [Related]  

  • 12. Buprenorphine withdrawal in a toddler.
    Levine M; Ruha AM
    Ann Emerg Med; 2009 Sep; 54(3):477-8. PubMed ID: 19695424
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction between lopinavir/ritonavir and warfarin.
    Hughes CA; Freitas A; Miedzinski LJ
    CMAJ; 2007 Aug; 177(4):357-9. PubMed ID: 17698824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ritonavir-fluticasone interaction causing Cushing syndrome in HIV-infected children and adolescents.
    Arrington-Sanders R; Hutton N; Siberry GK
    Pediatr Infect Dis J; 2006 Nov; 25(11):1044-8. PubMed ID: 17072128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maculo-papular rash induced by lopinavir/ritonavir.
    Calista D
    Eur J Dermatol; 2005; 15(2):97-8. PubMed ID: 15757820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of sleep-disordered breathing with opioid withdrawal.
    Ramar K
    Pain Pract; 2009; 9(5):394-8. PubMed ID: 19549061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
    Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML
    Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal syndrome is not precipitated when butorphanol is added to opiate or opioid therapy. A comment on intranasal butorphanol-induced apraxia reversed by naloxone.
    Barkin RL
    Pharmacotherapy; 1996; 16(5):969. PubMed ID: 8888097
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute opioid withdrawal precipitated by blood transfusion in a 21-year-old male.
    Kaddoum RN; Burgoyne LL; Pereiras LA; Bikhazi GB
    J Pain Symptom Manage; 2009 Oct; 38(4):e10-2. PubMed ID: 19699051
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug therapy of opioid withdrawal].
    Cortese S; Risso M
    Vertex; 2008; 19(77):522-6. PubMed ID: 18443666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.